570 / 1726
GUSTAVE ROUSSY
THÈME DU DIAPORAMA
Comparison 1
NACT followed by RT vs RT
18 trials
N = 2074
92% of patients from all eligible trials
Survival data available from all trials
Median FU – 5.7 years
70% pts had stage II or III disease
Lymph node status unknown in 60%